Randomised double blind phase III safety and efficacy trial of the proposed trastuzumab biosimilar, MYL-1401O vs. herceptin
Randomised double blind phase III safety and efficacy trial of the proposed trastuzumab biosimilar, MYL-1401O vs. herceptin
Phase II study of intraperitoneal versus intravenous chemotherapy following neoadjuvant chemotherapy and optimal debulking surgery in epithelial ovarian cancer
Temozolomide after radiotherapy improves glioma survival
Editor's Choice for May 2016
Mechanistic studies of DNA repair
Hodgkins - update on treatment strategies in children and adolescents
Use of novel agents in childhood ALL
Oncology for children: what can be done when resources are scarce?
Radiotherapy in Hogkin lymphoma: reducing risk in later life
Relapsed Hodgkin lymphoma in PET positive patients
Entrectinib, a novel treatment for TRK fusions, shows early promise against a range of cancer types
First outcome results from MINDACT breast cancer clinical trial